SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031385
Filing Date
2024-08-12
Accepted
2024-08-12 17:29:59
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1169017
2 ex31-1.htm EX-31.1 18525
3 ex31-2.htm EX-31.2 18218
4 ex32-1.htm EX-32.1 8454
5 ex32-2.htm EX-32.2 8945
  Complete submission text file 0001493152-24-031385.txt   7018159

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20240630.xsd EX-101.SCH 48880
7 XBRL CALCULATION FILE cdt-20240630_cal.xml EX-101.CAL 63631
8 XBRL DEFINITION FILE cdt-20240630_def.xml EX-101.DEF 263495
9 XBRL LABEL FILE cdt-20240630_lab.xml EX-101.LAB 444471
10 XBRL PRESENTATION FILE cdt-20240630_pre.xml EX-101.PRE 380315
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1123182
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 241198073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)